|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 31/4184 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3158991 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16020363.4 |
| Date of filing the European patent application | 2011-01-28 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation | 2021-07-12 |
| (30) | Number | Date | Country code |
| 299100 P | 2010-01-28 | US |
| (72) |
Palepu, Nagesh R., US
Buxton, Philip Christopher, GB
|
| (73) |
Eagle Pharmaceuticals, Inc.,
50 Tice Boulevard, Woodcliff Lake, NJ 07677,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bendamustino kompozicijos |
| FORMULATIONS OF BENDAMUSTINE |
| Payment date | Validity (years) | Amount | |
| 2025-12-31 | 16 | 347.00 EUR |
| 2027-01-28 |